Asia Pacific Aug 30, 2021
Observers puzzled by delays in China's approval of BioNTech-Pfizer vaccine
Some believe Beijing may be concerned that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than Western ones.
